Before we get to 2023, let’s talk about 2022—specifically about a technology that DIDN’T fulfill its promise last year: cryptocurrency. It was a genuinely cataclysmal year for crypto. Read crypto blogger Molly White’s jaw-dropping list for the details on just… Continue Reading
In 2005 and 2009, I published HEOR studies that led to an 80% drop in the number of US women who had their ovaries removed at the time of hysterectomy. Over the 17 years since our first paper came out,… Continue Reading
Performing and using cost-effectiveness analyses is a core activity for many of us working in HEOR. Many shortcomings of CEA are well known (it fails to account for budget impact, “real option value”, “the value of hope”, etc.), but CEA as currently performed has an even bigger problem than any of those: equity. Continue Reading
Gathering experts and soliciting their advice is a time-honored tactic. But methods for doing so invariably involve meeting in person. Although the threat of COVID-19 appears to be slowly receding, business travel may take years to return to pre-crisis levels.… Continue Reading
19. As in COVID. Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. Continue Reading
